OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TREM2 regulates innate immunity in Alzheimer’s disease
Jiangtao Li, Ying Zhang
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
Harald Hampel, Filippo Caraci, A. Claudio Cuello, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 266

Neuroinflammation in Alzheimer’s Disease
Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária Čarná, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 524-524
Open Access | Times Cited: 209

TREM2 ectodomain and its soluble form in Alzheimer’s disease
Jiaolong Yang, Zhihui Fu, Xingyu Zhang, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 88

Systemic and CNS Inflammation Crosstalk: Implications for Alzheimer’s Disease
Evi Paouri, Spiros Georgopoulos
Current Alzheimer Research (2019) Vol. 16, Iss. 6, pp. 559-574
Closed Access | Times Cited: 86

Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities
Hailan Yao, Kyle Coppola, Jonas Elias Schweig, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 84

Implications of Glycosylation in Alzheimer’s Disease
Henriette Haukedal, Kristine Freude
Frontiers in Neuroscience (2021) Vol. 14
Open Access | Times Cited: 84

Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases
Jeyashree Alagarsamy, Anja Jaeschke, David Y. Hui
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9892-9892
Open Access | Times Cited: 42

Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?
Simone Lista, Bruno P. Imbimbo, Margherita Grasso, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 16

Brain Injury–Mediated Neuroinflammatory Response and Alzheimer’s Disease
Duraisamy Kempuraj, Mohammad Ejaz Ahmed, Govindhasamy Pushpavathi Selvakumar, et al.
The Neuroscientist (2019) Vol. 26, Iss. 2, pp. 134-155
Open Access | Times Cited: 75

Reformulating Pro-Oxidant Microglia in Neurodegeneration
Juan García‐Revilla, Isabel M. Alonso-Bellido, Miguel Ángel Burguillos, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 10, pp. 1719-1719
Open Access | Times Cited: 57

Alzheimer’s disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation
Shehata Anwar, Serge Rivest
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 4, pp. 331-344
Closed Access | Times Cited: 57

Targeting Microglia-Synapse Interactions in Alzheimer’s Disease
Gaia Piccioni, Dalila Mango, Amira Saidi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2342-2342
Open Access | Times Cited: 47

TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation
Lorenza Magno, Tom D. Bunney, Emma Mead, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 44

Alzheimer’s disease risk reduction in clinical practice: a priority in the emerging field of preventive neurology
Kellyann Niotis, Corey Saperia, Nabeel Saif, et al.
Nature Mental Health (2024) Vol. 2, Iss. 1, pp. 25-40
Closed Access | Times Cited: 7

TGF-β1 Restores Hippocampal Synaptic Plasticity and Memory in Alzheimer Model via the PI3K/Akt/Wnt/β-Catenin Signaling Pathway
Hu Y, Wei Chen, Lin Wu, et al.
Journal of Molecular Neuroscience (2018) Vol. 67, Iss. 1, pp. 142-149
Closed Access | Times Cited: 53

CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: Implications in tauopathies
Sara Castro‐Sánchez, Ángel J. García‐Yagüe, Sebastian Kügler, et al.
Redox Biology (2019) Vol. 22, pp. 101118-101118
Open Access | Times Cited: 50

Emerging Alzheimer’s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions
Nour S. Tobeh, Kimberley D. Bruce
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 15

Decoding sTREM2: its impact on Alzheimer’s disease – a comprehensive review of mechanisms and implications
Cui Lin, Yu Kong, Qian Chen, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5

Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3)
Yijun Wang, Alina Monteagudo, Matthew A. Downey, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 30

Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology
Dominique Gouilly, Marie Rafiq, L Nogueira, et al.
Revue Neurologique (2023) Vol. 179, Iss. 8, pp. 812-830
Closed Access | Times Cited: 12

Single cell transcriptome analysis of the THY-Tau22 mouse model of Alzheimer’s disease reveals sex-dependent dysregulations
Muhammad Ali, Pierre Garcia, Laetitia Lunkes, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4

The potential link between the development of Alzheimer’s disease and osteoporosis
Fariha Nasme, Jyotirmaya Behera, Prisha Tyagi, et al.
Biogerontology (2025) Vol. 26, Iss. 1
Closed Access

Microglia in Alzheimer's Disease: A Role for Ion Channels
Laura Thei, Jennifer Imm, Eleni Kaisis, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 35

Page 1 - Next Page

Scroll to top